-+ 0.00%
-+ 0.00%
-+ 0.00%

HERANTIS PHARMA - PHASE 1B BIOMARKER DATA SHOW CLEAR EVIDENCE OF BIOLOGICAL RESPONSE TO HER-096 IN PEOPLE WITH PARKINSON'S DISEASE

Reuters·01/07/2026 18:01:13

Please log in to view news